Found 5 Enz. Inhib. hit(s) with Target = 'Steroid hormone receptor ERR2' and Ligand = 'BDBM485065' TargetSteroid hormone receptor ERR2(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Affinity DataIC50: 4.82E+3nMAssay Description:ERRα/ERRβ/ERα : In an ERR beta binding assay, GST-bound ERR alpha LBD was used so that a final concentration was 10 nM and a fluoresce...More data for this Ligand-Target Pair
TargetSteroid hormone receptor ERR2(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Affinity DataIC50: 4.82E+3nMAssay Description:In an ERR alpha binding assay, GST-bound ERR alpha LBD was used, and all experiments other than that was the same as the ERR gamma binding assay.In a...More data for this Ligand-Target Pair
TargetSteroid hormone receptor ERR2(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Affinity DataIC50: 6.77E+3nMAssay Description:In an ERR alpha binding assay, GST-bound ERR alpha LBD was used, and all experiments other than that was the same as the ERR gamma binding assay.In a...More data for this Ligand-Target Pair
TargetSteroid hormone receptor ERR2(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Affinity DataIC50: 6.77E+3nMAssay Description:ERRα/ERRβ/ERα : In an ERR beta binding assay, GST-bound ERR alpha LBD was used so that a final concentration was 10 nM and a fluoresce...More data for this Ligand-Target Pair
TargetSteroid hormone receptor ERR2(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Daegu-Gyeongbuk Medical Innovation Foundation
US Patent
Affinity DataIC50: 6.77E+3nMAssay Description:Binding affinity to ERRbeta (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
